Prediction Of Response To Neoadjuvant Breast Cancer Therapy By Magnetic Resonance Imaging (MRI)
Funder
National Health and Medical Research Council
Funding Amount
$67,321.00
Summary
Neoadjuvant chemotherapy (NAC) has a well-established role in the management of breast cancer. Various roles have been proposed for magnetic resonance imaging (MRI) in the NAC setting, including its application in prediction of final pathologic response when undertaken early during a planned NAC course; the detection of residual disease after completion of NAC; and the measurement of residual tumour extent. The present study aims to determine the accuracy of MRI (relative to other imaging and cl ....Neoadjuvant chemotherapy (NAC) has a well-established role in the management of breast cancer. Various roles have been proposed for magnetic resonance imaging (MRI) in the NAC setting, including its application in prediction of final pathologic response when undertaken early during a planned NAC course; the detection of residual disease after completion of NAC; and the measurement of residual tumour extent. The present study aims to determine the accuracy of MRI (relative to other imaging and clinical tests) in these clinical scenarios.Read moreRead less